Health TrialsbyHealthPanel

Yoga for Young Adults Affected by Cancer

ConditionsYoung Adult CancerYoung Adult Oncology
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Calgary

About this trial

Yoga may enhance physical and psychological outcomes among young adults affected by cancer. Yet, yoga has rarely been studied in this population. We developed and piloted a yoga program, which is now ready for implementation and evaluation. This single-group, mixed-methods project will explore effectiveness and implementation of the yoga program.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult aged 18 years or older;

Diagnosed with cancer between the ages of 18-39 years;

At any stage of their cancer experience (i.e., on- or off-treatment);

Able to safely engage in yoga, as assessed by completing the Get Active Questionnaire and obtaining medical clearance (if indicated).

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Yoga

    Behavioral

    Participants receive the yoga program, which is delivered by a trained yoga instructor (completed at least a 200-hour yoga teacher training, Yoga Thrive Teacher Training Certification (or similar), and/or practical experience working with individuals affected by cancer). The first class of the week is comprised of 45 minutes of gentle, progressive, hatha-based yoga sequencing and postures with the last 15 minutes focused on guided behaviour change and mindfulness techniques that varies week-to-week, based on the participants in the class. The second class of the week is 60 minutes of gentle, yin-based yoga sequencing and postures with an element of opening and relaxing.

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: YogaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Reach

The number of people who participate, and reasons why or why not.

Time frame
Through study completion, an average of 5 years

Secondary outcomes

1

Attendance

Number of classes attended out of the number of classes offered by study staff.

Time frame
Through study completion, an average of 5 years
2

Adherence

Number of classes attended out of the number of classes offered by study staff.

Time frame
Through study completion, an average of 5 years
3

Missing data

Percentage of missing data on quantitative measures and completion of qualitative interviews.

Time frame
Through study completion, an average of 5 years
4

Barriers and facilitators to exercise participation

Change in Barrier Self-Efficacy Scale (1). Scale range 0-100; higher scores indicates less barriers to participation.

Time frame
Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Calgary

Lead sponsor

Canadian Cancer Society (CCS)

Collaborator

Canadian Institutes of Health Research (CIHR)

Collaborator

Source ClinicalTrials.gov
Apply now